Literature DB >> 22047565

Therapy for cystic fibrosis--the end of the beginning?

Pamela B Davis.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 22047565     DOI： 10.1056/NEJMe1110323

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  10 in total

1.  New challenges in the diagnosis and management of cystic fibrosis.

Authors:  Hara Levy; Philip M Farrell
Journal:  J Pediatr       Date:  2015-06       Impact factor: 4.406

Review 2.  Ivacaftor: a novel mutation modulating drug.

Authors:  Harit Kapoor; Astha Koolwal; Ankur Singh
Journal:  J Clin Diagn Res       Date:  2014-11-20

3.  Improving transition from paediatric to adult cystic fibrosis care: programme implementation and evaluation.

Authors:  Megumi J Okumura; Thida Ong; Diana Dawson; Dennis Nielson; Nancy Lewis; Martha Richards; Claire D Brindis; Mary Ellen Kleinhenz
Journal:  BMJ Qual Saf       Date:  2014-01-10       Impact factor: 7.035

Review 4.  Cystic fibrosis: a clinical view.

Authors:  Carlo Castellani; Baroukh M Assael
Journal:  Cell Mol Life Sci       Date:  2016-10-05       Impact factor: 9.261

5.  Targeting autophagy as a novel strategy for facilitating the therapeutic action of potentiators on ΔF508 cystic fibrosis transmembrane conductance regulator.

Authors:  Alessandro Luciani; Valeria Rachela Villella; Speranza Esposito; Manuela Gavina; Ilaria Russo; Marco Silano; Stefano Guido; Massimo Pettoello-Mantovani; Rosa Carnuccio; Bob Scholte; Antonella De Matteis; Maria Chiara Maiuri; Valeria Raia; Alberto Luini; Guido Kroemer; Luigi Maiuri
Journal:  Autophagy       Date:  2012-08-09       Impact factor: 16.016

6.  Novel amino-carbonitrile-pyrazole identified in a small molecule screen activates wild-type and ΔF508 cystic fibrosis transmembrane conductance regulator in the absence of a cAMP agonist.

Authors:  Wan Namkung; Jinhong Park; Yohan Seo; A S Verkman
Journal:  Mol Pharmacol       Date:  2013-06-20       Impact factor: 4.436

7.  A reliable computational workflow for the selection of optimal screening libraries.

Authors:  Yocheved Gilad; Katalin Nadassy; Hanoch Senderowitz
Journal:  J Cheminform       Date:  2015-12-11       Impact factor: 5.514

8.  Multicenter Surveillance of Cystic Fibrosis in Korean Children.

Authors:  Hyung Young Kim; Soo-Jong Hong; Kangmo Ahn; Dong In Suh; Shin Hye Noh; Soo Yeon Kim; Jinho Yu; Jung Min Ko; Min Goo Lee; Kyung Won Kim
Journal:  Allergy Asthma Immunol Res       Date:  2022-09       Impact factor: 5.096

9.  The effect of whole body vibration exposure on muscle function in children with cystic fibrosis: a pilot efficacy trial.

Authors:  Kaitlin O'Keefe; Rhonda Orr; Peite Huang; Hiran Selvadurai; Peter Cooper; Craig Frank Munns; Maria A Fiatarone Singh
Journal:  J Clin Med Res       Date:  2013-04-23

10.  Targeting the Intracellular Environment in Cystic Fibrosis: Restoring Autophagy as a Novel Strategy to Circumvent the CFTR Defect.

Authors:  Valeria Rachela Villella; Speranza Esposito; Emanuela M Bruscia; Maria Chiara Maiuri; Valeria Raia; Guido Kroemer; Luigi Maiuri
Journal:  Front Pharmacol       Date:  2013-01-21       Impact factor: 5.810
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.